logo    Company Page

Most Recent Insiders Activity

Transaction Date Company Name Insider Name (Title) Activity Stock Acquired or Disposed Shares Price range Amount
2024-04-01 Beam Therapeutics Inc. Simon Amy
(Chief Medical Officer)
S Common Stock D 23687 $30.54 - $32.13 $734,804
2024-04-01 Beam Therapeutics Inc. Bellon Christine
(Chief Legal Officer)
S Common Stock D 3401 $32.12 - $32.12 $109,240
2024-04-01 Beam Therapeutics Inc. Burrell Terry-Ann
(Chief Financial Officer)
S Common Stock D 5446 $32.12 - $32.12 $174,925
2024-04-01 Beam Therapeutics Inc. Evans John M.
(CEO)
S Common Stock D 18102 $32.13 - $32.13 $581,617
2024-04-01 Beam Therapeutics Inc. Ciaramella Giuseppe
(President)
S Common Stock D 4534 $32.12 - $32.12 $145,632
2024-03-28 Beam Therapeutics Inc. Evans John M.
(CEO)
S Common Stock D 60000 $33.86 - $33.86 $2,031,401
2024-03-31 Beam Therapeutics Inc. Evans John M.
(CEO)
A Common Stock A 77500 $0.00 - $0.00 $0
2024-02-13 Beam Therapeutics Inc. FMR LLC
()
S Common Stock D 901565 $30.28 - $31.34 $27,545,049
logo   

Please upgrade to premium to see all results. Signup if you don't have an account.

Login Signup
Activity types
A Grant, award or other acquisition
C Conversion of Derivative or Security
D Disposition to the issuer of issuer equity securities
E Expiration of short derivative position
F Payment of exercise price or tax liability
G Bona fide Gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary Transaction
J Other acquisition or disposition
K Transaction in equity swap or instrument with similar characteristics
L Small Acquisition
M Exercise or conversion of derivative security
O Exercise of out-of-the-money derivative security
P Open Market Purchase
S Open Market Sale
U Disposition pursuant to a tender of shares in a change of control transaction
V Transaction Voluntarily Reported
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust
Debug Info- Version: 2.6